¿¬¼ö°­ÁÂ
¼Ò¾Æ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö : 2023-11-17

¼Ò¾Æ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö : 2023-11-17
±³À°ÀÏÀÚ : 2023-11-17
±³À°Àå¼Ò : û´ã¸®º£¶óÈ£ÅÚ º£¸£»çÀÌÀ¯È¦

±³À°ÁÖÁ¦ : ¼Ò¾Æ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 14:00~14:15 Standare risk ALL(acute lymphoblastic leukemia) ÁÖÈñ¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 14:15~14:30 High risk ALL(acute lymphoblastic leukemia) ÀÌÀç¿í(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 14:30~14:45 Very high risk ALL(acute lymphoblastic leukemia) ±èº¸°æ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 14:45~15:00 Infnat ALL(acute lymphoblastic leukemia) Çѽ¹Î(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 15:00~15:15 Relapsed ALL(acute lymphoblastic leukemia) ±èÇý¸®(¿ï»êÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 15:25~15:40 clinical application of NGS MRD in pediatric ALL(acute lymphoblastic leukemia) È«°æÅÃ(¼­¿ïÀÇ´ë )

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 15:40~15:55 Comprehensive genomin analysis project for pediatric hematologic malignancies ±è¸í½Å(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 15:55~16:10 CAR-T cell therpay for pediatric ALL(acute lymphoblastic leukemia)  requiring HSCT(hematopoietic stem cell transplantation) °­ÇüÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 16:40~17:20 Treatment of pediatric cancer À¯Ã¶ÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ º£¸£»çÀÌÀ¯È¦ 17:20~18:00 Basic conecpt hematopoietic stem cell and leukemia stem cell Á¶ºó(°¡Å縯ÀÇ´ë )

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,253 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Surgeon : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : °­³²¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Sur

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,547 , ´ñ±Û¼ö : 0

[´ë±¸] Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­Á : 2024-03-24

±³À°ÀÏÀÚ : 2024-03-24 ±³À°Àå¼Ò : ´ë±¸ ÀÎÅÍºÒ°í ¸¸Ã̵¿ ÄÁº¥¼ÇȦ 2Ãþ ±³À°ÁÖÁ¦ : Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ ½ÃÇà±â

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,620 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 16th Vascular Ultrasound Seoul Update 2023 Symposium (2ÀÏÂ÷) : 2024-04-21

±³À°ÀÏÀÚ : 2024-04-21 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 16th Vascular Ultrasound Seoul Update 2023

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,426 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-16

±³À°ÀÏÀÚ : 2024-03-16 ±³À°Àå¼Ò : ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,546 , ´ñ±Û¼ö : 0